The Global Hydrogel-based Drug System Market Size will Hit $9.3 Billion by 2027, at a CAGR of 8%

Hydrogel-based Drug System Market Growth, Trends and Report Highlights

According to a new report Global Hydrogel-based Drug Delivery System Market, published by KBV research, The Global Hydrogel-based Drug Delivery System Market size is expected to reach $9.3 billion by 2027, rising at a market growth of 8% CAGR during the forecast period.

The subcutaneous drug delivery segment would witness prominent growth rate in the hydrogel-based drug delivery system market during the forecast period. Hydrogel is a biodegradable material, so they are widely utilized in the development of subcutaneous drug delivery systems. The implants get damage naturally in the body so the requirement for its surgical removal is eradicated. Several subcutaneous hydrogel implants are newly made to gain the controlled release of anticancer drugs.

The natural segment acquired the largest revenue share in the hydrogel-based drug delivery system market in 2020. On the basis of polymer origin, hydrogel can be segmented into three main categories: synthetic, natural, and hybrid. Proteins like lysosome, gelatin, and collagen; and polysaccharides like hyaluronic acid, chitosan, and alginate are utilized in the making of natural hydrogels.

North America emerged as a leading region in the hydrogel-based drug delivery systems market in 2020. The presence of effective compensation, which includes the cost of modern therapies, the presence of key hydrogel suppliers, and recurrent product releases are among the major aspects felling the regional market growth.

Full Report: https://www.kbvresearch.com/hydrogel-based-drug-system-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson & Johnson, Bausch Health Companies, Inc., Medtronic PLC, Galderma S.A., Endo International PLC, Ferring Holdings SA, Akorn Operating Company LLC, Tolmar Pharmaceuticals, Inc., Blairex Laboratories, Inc., and Ocular Therapeutix, Inc.

Global Hydrogel-based Drug System Market Segmentation

By Polymer Origin

• Synthetic
• Natural
• Hybrid

By Delivery Route

• Ocular
• Subcutaneous
• Oral Cavity
• Topical
• Other Delivery Routes

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Johnson & Johnson
• Bausch Health Companies, Inc.
• Medtronic PLC
• Galderma S.A.
• Endo International PLC
• Ferring Holdings SA
• Akorn Operating Company LLC
• Tolmar Pharmaceuticals, Inc.
• Blairex Laboratories, Inc.
• Ocular Therapeutix, Inc.

Related Reports:

North America Hydrogel-based Drug System Market Size to 2027

• September-2021
• 61 Pages

LAMEA Hydrogel-based Drug System Market Size Report to 2027

• September-2021
• 71 Pages

Europe Hydrogel-based Drug System Market Size Report 2027

• September-2021
• 71 Pages

Asia Pacific Hydrogel-based Drug System Market Size to 2027

• September-2021
• 71 Pages